Digital device for reading allergy skin prick tests

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the effectiveness of a digital device, Nexkin DSPT, in reading skin prick tests (SPTs) for allergies. SPTs are commonly used to diagnose allergies but are traditionally performed manually, which can introduce variability and subjectivity in results. The study aims to automate and digitize the reading process, providing more consistent and objective results. Participants will undergo skin prick tests with various allergens, and the digital device will be compared to standard manual readings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients who will undergo skin prick tests with panels of aeroallergens and/or foods.

Over 18 years of age. The patient or their representative has given consent to participate in the study.

The patient must not have taken an antihistamine in the last 5 days.

Exclusion Criteria:

Patients who are evaluated by more than 40 prick tests. Patients who have taken an antihistamine within the previous 5 days. Patients who are being treated with antidepressants or other drugs with an antihistamine effect.

Patients who suffer severe atopic dermatitis with forearm involvement. Patients with dermographism. Patients who are evaluated by intradermal testing. Pregnant women or women suspected to be pregnant. Vulnerable patients

Where it's running

• Inselspital, Bern University Hospital, University of Bern
  Bern, Switzerland Recruiting

Study contacts

• Principal investigator: Elnaz Arjmand — Inselspital, Bern / sitem-Insel AG

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms

  This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07923084

• Pediatric Outpatient Health Data Cohort in Switzerland

  This study tests the PROS-CH data-collection system in pediatric primary care to see if routine tools can build a useful cohort of children under age 2 for common health issues.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07911228

• Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes

  This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.

  Recruiting at 5 sites Insel Gruppe AG, University Hospital Bern · Zabrze and 4 other locations · NCT07852221

• Left vs right subthalamic nucleus deep brain stimulation: how it changes thinking and mood in Parkinson’s

  This study tests whether turning DBS on the left or the right side of the brain changes cognition and mood in people with Parkinson’s disease.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07777419

• Depth of Argon Beam Coagulation in Ovarian Endometriomas

  This study tests how deeply Argon Beam Coagulation affects ovarian tissue during laparoscopic surgery for ovarian endometriomas in women aged 18-40.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern, Canton of Bern · NCT07711743

• LITT for ultra-early GBM recurrence within 1 week of pre-radiation planning

  This study tests whether a minimally invasive laser treatment can destroy an early GBM recurrence without delaying planned radiotherapy and chemotherapy.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07616986

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.